Archives

by in
Entry Author Date Location
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More 01/12/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Cure for Diabetes 12/28/11 San Francisco
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
FDA Clears Portable Insulin Pump from San Diego’s Tandem Diabetes 11/16/11 San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships 11/15/11 New York
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact 11/08/11 San Diego
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment 10/20/11 Boston
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund 10/17/11 San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial 10/07/11 Boston
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs 10/03/11 San Francisco
Elevation Partners Grabs $17M, NanoSort Wins Grants, NIH Collaborates with Afraxis on Rare Disease R&D, & More San Diego Life Sciences News 09/29/11 San Diego
AdverseEvents.com Seeks to Keep Track of Drug Side Effects the Way the FDA Never Could 09/27/11 San Francisco
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News 09/16/11 Boston
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity 09/14/11 Boston
Valeritas Raises $150M for Insulin Device 09/13/11 New York
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News 09/02/11 Boston
GI Dynamics Raises $85M USD in Aussie IPO 08/30/11 Boston
Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News 08/25/11 San Diego
San Diego’s Tandem Diabetes Raises $12 Million While Insulin Pump Is Under Review 08/22/11 San Diego
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Page 3 of 11 « previous page · next page »